Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta

PLoS One. 2021 Mar 4;16(3):e0248027. doi: 10.1371/journal.pone.0248027. eCollection 2021.

Abstract

Molecular chaperon SERPINA3 colocalizes with accumulated amyloid peptide in Alzheimer's disease (AD) patient's brain. From the QTL analysis, we narrowed down Serpina3 with two SNPs in senescence-accelerated mouse prone (SAMP) 8 strain. Our study showed SAMP8 type Serpina3 prolonged retention of oligomeric Aβ 42 for longer duration (72 hr) while observing under transmission electron microscope (TEM). From Western blot results, we confirmed presence of Aβ 42 oligomeric forms (trimers, tetramers) were maintained for longer duration only in the presences of SAMP8 type Serpina3. Using SH-SY5Y neuroblastoma cell line, we observed until 36 hr preincubated Aβ 42 with SAMP8 type Serpina3 caused neuronal cell death compared to 12 hr preincubated Aβ 42 with SAMR1 or JF1 type Serpina3 proteins. Similar results were found by extending this study to analyze the effect of polymorphism of SERPINA3 gene of the Japanese SNP database for geriatric research (JG-SNP). We observed that polymorphic SERPINA3 I308T (rs142398813) prolonged toxic oligomeric Aβ 42 forms till 48 hr in comparison to the presence wild type SERPINA3 protein, resulting neuronal cell death. From this study, we first clarified pathogenic regulatory role of polymorphic SERPINA3 in neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / genetics*
  • Acute-Phase Proteins / metabolism
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Cell Line, Tumor
  • Humans
  • Male
  • Mice
  • Peptide Fragments / analysis
  • Peptide Fragments / metabolism*
  • Polymorphism, Single Nucleotide*
  • Protein Multimerization
  • Quantitative Trait Loci
  • Serpins / genetics*
  • Serpins / metabolism

Substances

  • Acute-Phase Proteins
  • Amyloid beta-Peptides
  • Peptide Fragments
  • SERPINA3 protein, human
  • Serpina3n protein, mouse
  • Serpins
  • amyloid beta-protein (1-42)

Grants and funding

This study was supported by the following grants: -The Grant-in-Aid for Scientific Research (KAKENHI) Grant number: 07805510 to MI -The Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and Development (AMED) Grant number: 15657579 to MI -The Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development (AMED) Grant number: 19187977 and 20333128 to MI -The Toyama Pharmaceutical Valley Development Consortium (to MI; no grant number assigned) -The Hokuriku Life Science Cluster (to MI; no grant number assigned)